Navigation Links
ChanTest Announces a Global Campaign to Share New Findings and Developments in Cystic Fibrosis (CF) Research
Date:8/14/2014

Cleveland, OH (PRWEB) August 14, 2014

With over 70,000 people suffering from cystic fibrosis (CF) worldwide, and 30,000 alone in the United States, the world is searching for impactful solutions to address the pain and suffering endured by people living with this debilitating disease.

To this end, ChanTest has announced a global campaign to share new findings and developments in CF research through the publication of a new, cutting-edge white paper entitled “Unfolding Cystic Fibrosis Research”. As a leader in supporting the drug discovery and development industry, ChanTest has played a crucial role in progressing our worldwide understanding on how to solve critical CF challenges.

Cystic fibrosis causes the creation of a thick and sticky mucus, which clogs important organs such as the lungs or the digestive system. CF is caused by a mutation in the gene for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Although there are over 1000 mutations that produce this disorder, the most common is the deletion of phenylalanine at position 508 of the CFTR protein (CFTR F508del). This results in the production of misfolded CFTR protein that is then rarely inserted into the cell membrane, where it belongs.

Nearly 90% of the CF population has at least one copy of the F508del mutation, which is why ChanTest focuses their research, and has produced this white paper, with an emphasis on ‘Unfolding’ cystic fibrosis.

The white paper not only focuses on the role of this important protein, but also discusses many scientific assay projects which have the potential to significantly affect those with cystic fibrosis. This testing and analysis, supported by assay work conducted by ChanTest, helps to show what methods, and therefore what drugs, are most effective in treating this disorder and its symptoms.

According to Dr. Anthony Lacerda, Director of Contract Research and Development a
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. ChanTest Announces a Global Campaign to Share New Findings and Developments in Cystic Fibrosis Research
2. ChanTest Announces Third User Meeting: Partnerships in Drug Discovery
3. ChanTest Announces ChansPorter™ Assays to Accelerate Drug Development for Cystic Fibrosis Patients
4. Phytomer Announces REMODÈLE Tonic Body Gel
5. Major Pipette Distributor Pipette.com Announces the Addition of the VistaLab Ovation M Pipette to their Product Line
6. Poison Prevention Week Council Announces Poster Contest Winners
7. Appy Pie Announces BRB Oldies Radio as App of the Month
8. FitBody Personal Training, LLC Announces New Cardio Blast Class
9. ForeverGreen Worldwide Corporation Announces Conference Call
10. Insight To Recovery Announces "No One Turned Away For Drug and Alcohol Treatment" Campaign
11. Holon Solutions Announces that the State of Texas is Using Its Health Information Exchange (HIE) Technology to Help More Smokers Kick the Tobacco Habit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... York, NY (PRWEB) September 21, 2014 ... designs, develops, implements and supports electronic medical records ... significantly benefited from federal healthcare legislation during the ... to do so during the five years to ... and Clinical Health Act established Medicare and Medicaid ...
(Date:9/21/2014)... 2014 Originally approved by the ... Flovent (fluticasone propionate) is a synthetic ICS therapy ... the maintenance treatment of asthma prophylactically in children ... formulations, Diskus and HFA, which received the FDA ... ingredient, fluticasone propionate, can bind to glucocorticoid receptors ...
(Date:9/21/2014)... September 21, 2014 More than ... been added over the past month to a ... serious cardiovascular injuries caused by the dialysis concentrate, ... updated on September 15th shows 2,089 cases filed ... District Court, District of Massachusetts. These claims were ...
(Date:9/21/2014)... 21, 2014 Developers and plugin specialist ... announced a new transition plugin entitled Transpack Vol. 3 ... high quality transitions that will add a level of ... CEO of Pixel Film Studios. “Blurring the line between ... game changer.” , Transpack Vol. 3 returns with over ...
(Date:9/21/2014)... Top10BestSEOHosting.com, a leading review website, has recently ... the most recommended hosting suppliers for the webmasters ... products. , “Don’t waste your time on ... great hosting companies to you,” the IT manager ... GreenGeeks are the most recommended suppliers for everyone. ...
Breaking Medicine News(10 mins):Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 4Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 3Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 4Health News:Pixel Film Studios Released Transpack Vol. 3 Plugin Exclusively for Final Cut Pro X 2Health News:Leading Review Website Top10BestSEOHosting.com Unveils The Best Hosting Suppliers In September 2
... step up health tourism investment along the lines of Kerala, ... // ,"Being a source of rare Himalayan herbs ... Lahe-Thapa, the Nepal Tourism Board's director of marketing and promotion, ... (in southern India), Thailand and Malaysia, we will be looking ...
... into overweight children than formula-fed babies, says a study. // ... US are overweight, according to government statistics. This accounts for ... years, reported an online edition of health magazine WebMD. ... studied 15,253 children between the ages of nine and 14 ...
... once again offered a valuable insight for one of the ... // Red wine has always hogged a fair share of ... brain. A recent study seems to suggest that Red wine ... looking for! ,The researchers, from Mount Sinai School ...
... Health Department has announced that it is adequately ... as well as // control measures, to counter ... Kerala, Thiruvananthapuram, Alappuzha, Ernakulum and Kozhikode have reported ... slackened response by the Health watch dogs, Ms. ...
... A Ukrainian has invented a condom that plays music ... Chausovsky developed the birth control device as a novelty, ... said. ,A miniature loudspeaker and motion sensor ... of musical tones during sex. ,The condom's ...
... into crosses, Y's and T's, Cornell researchers have created ... into any desired shape for biomedical applications. ,Hydrogels ... cross-linked to one another to create many small empty ... a sponge. If the spaces are filled with a ...
Cached Medicine News:Health News:Nepal Plans to Promote Health Tourism Based on Traditional Medicine 2Health News:Synthetic DNA Makes Better Hydrogels for Drug Delivery 2
(Date:9/19/2014)... WHITEHOUSE STATION, N.J. , Sept. 19, 2014 Merck ... the United States and Canada , ... on Desafiando La Diabetes: Logra Tus Metas , an educational ... of their blood sugar -- a key treatment goal to help ... the United States are at a higher risk for ...
(Date:9/19/2014)... Five MinuteClinic walk-in medical clinics are opening inside select CVS/pharmacy stores ... opened in Memphis and Cordova ... in Springfield on September 24 and a ... open October 22.  MinuteClinic is the largest and fastest growing provider ... . The Memphis -area clinics join ...
(Date:9/19/2014)... Mass. , Sept. 19, 2014  Pressure ... today announced it has received and approved all ... HT48 instruments and has begun to manufacture the ... first instrument will be ready for shipment by ... built and released at a rate of about ...
Breaking Medicine Technology:Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3
... June 27 /CNW/ -,Aspreva Pharmaceuticals Corporation (NASDAQ: ASPV; ... a clinical trial,comparing CellCept (oral mycophenolate mofetil, MMF) ... of care, for,inducing treatment response in the induction ... rates were similar in both arms, the trial ...
... WIRE)--Jun 27, 2007 - PrimeCell(TM),Therapeutics LLC (http://www.primecelltherapeutics.com) ... pre-clinical,studies for a clinical trial to assess ... bone marrow stem cells into,spinal cord injury ... preliminary report at the 13th,Annual Meeting of ...
Cached Medicine Technology:Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 2Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 3Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 4Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 5Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 6Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 7Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 8Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for,Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical,Study 2
... Heavy Duty is a pressure relief mattress overlay ... specifically to the BariKare® Bed., ,INDICATIONS , ... lbs., Large patients at risk or suffering from ... mattress that would benefit from a pressure relief ...
... bariatric bed system which helps provide comfort ... care setting, ,INDICATIONS: ,Patients weighing up ... 2) ,Healthcare frame accommodating one or two ... ,CONTRAINDICATION: ,Total weight in excess of ...
... The BariMaxx™ is a full-featured healthcare ... environment for the care and management of ... up to 1000 lbs. ,Large patients at ... weight in excess of 1000 lbs. (including ...
EC+ Extra Care Bariatric Bed...
Medicine Products: